A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum]

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353206/
https://www.ncbi.nlm.nih.gov/pubmed/30774301
http://dx.doi.org/10.2147/OPTH.S201658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353206/
https://www.ncbi.nlm.nih.gov/pubmed/30774301
http://dx.doi.org/10.2147/OPTH.S201658

Ejemplares similares